Financial statements Polypharm

Balance sheet of Polypharm

Company age:
Age:
24 y. 17 d.
Share capital:
Share capital:
500 000 PLN

Balance sheet data of POLYPHARM

Year
2018
2021
2022
Total assets 22 828 062,20 20 270 749,00 21 968 816,69
A. Fixed assets 12 404 536,93 10 444 625,24 9 967 135,26
B. Current assets 10 368 116,45 9 826 123,76 12 001 681,43
C. Share capital contributions (basic funds) 55 408,82 0,00 0,00
D. Own shares (stocks) - 0,00 0,00
Total liabilities 22 828 062,20 20 270 749,00 21 968 816,69
A. Equity 15 296 088,34 16 063 296,21 15 978 500,19
B. Liabilities and provisions for liabilities 7 531 973,86 4 207 452,79 5 990 316,50
I. Long-term liabilities 787 100,03 126 741,00 114 139,94
II. Short-term liabilities 6 404 709,70 3 899 631,37 5 663 144,17
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.